* pSivida announces successful completion of two preclinical
studies of Durasert sustained-release insert delivering
repurposed cancer drug to treat wet amd
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom +1-646-223-8780)
Read more
No comments:
Post a Comment